Global Killer-cell immunoglobulin-like receptors (KIRs) Market Growth (Status and Outlook) 2026-2032
The global Killer-cell immunoglobulin-like receptors (KIRs) market size is predicted to grow from US$ 84.13 million in 2025 to US$ 154 million in 2032; it is expected to grow at a CAGR of 8.9% from 2026 to 2032.
Killer-cell immunoglobulin-like receptors (KIRs) are a family of transmembrane glycoprotein receptors mainly expressed on natural killer cells and subsets of T cells, and the term also refers to the related commercial products and services built around KIR proteins, KIR genes, ligand recognition, and functional immune analysis. They are not visible stand-alone devices, but molecular receptors located on the cell membrane, typically composed of extracellular immunoglobulin-like domains, a transmembrane region, and a cytoplasmic tail. Structurally, KIRs can contain two or three extracellular immunoglobulin-like domains, while functionally they include inhibitory and activating receptor types. Commercial products include genotyping kits, sequencing and testing services, flow cytometry antibodies, conjugated antibodies, recombinant proteins, plasmids, cell models, and reference antibodies for drug discovery. Their mechanism is based on recognizing human leukocyte antigen-related ligands and regulating natural killer cell cytotoxicity, immune tolerance, and immune surveillance. Major use scenarios include transplant immunogenetics, natural killer cell research, oncology immunology, immune phenotyping, therapeutic antibody discovery, cell therapy development, and reproductive immunology research.
Market growth opportunities are mainly supported by three demand streams. First, transplant immunogenetics and cell therapy are increasing the need to understand donor-recipient immune background, which supports demand for genotyping, receptor-ligand analysis, and immune risk assessment. Second, the rising importance of natural killer cells in oncology, infectious disease, and autoimmune research is expanding demand for flow cytometry antibodies, recombinant proteins, and functional validation materials. Third, more specific receptor targets are moving part of the market closer to translational development, especially in therapeutic antibody programs, immune monitoring, and potential companion testing workflows.
The main market challenges are clinical evidence, standardization, and commercial scale. These products are used mostly by specialized laboratories, transplant centers, academic institutes, and drug developers, so the customer base is much narrower than that of routine clinical diagnostics. Complex polymorphism, haplotype variation, gene copy number differences, and platform-specific interpretation create technical barriers in quality control and reporting. The value of routine KIR-based decision-making still requires stronger prospective evidence, so near-term market development should be assessed as steady professional adoption rather than mass-market expansion.
Downstream demand is expected to shift from single-product purchasing toward integrated solutions. Transplant-related users will increasingly combine genotyping, ligand matching, and long-term outcome data. Oncology immunology users will focus more on receptor expression, immune-cell functional status, and treatment response monitoring. Drug developers will require higher target specificity, antibody affinity validation, cytotoxicity mechanism studies, and clinical sample-based evidence. Faster-growing product categories are likely to include high-throughput typing, conjugated antibody panels, recombinant proteins, reference antibodies, and testing services designed for clinical research.
LPI (LP Information)' newest research report, the ?Killer-cell immunoglobulin-like receptors (KIRs) Industry Forecast? looks at past sales and reviews total world Killer-cell immunoglobulin-like receptors (KIRs) sales in 2025, providing a comprehensive analysis by region and market sector of projected Killer-cell immunoglobulin-like receptors (KIRs) sales for 2026 through 2032. With Killer-cell immunoglobulin-like receptors (KIRs) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Killer-cell immunoglobulin-like receptors (KIRs) industry.
This Insight Report provides a comprehensive analysis of the global Killer-cell immunoglobulin-like receptors (KIRs) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Killer-cell immunoglobulin-like receptors (KIRs) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Killer-cell immunoglobulin-like receptors (KIRs) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Killer-cell immunoglobulin-like receptors (KIRs) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Killer-cell immunoglobulin-like receptors (KIRs).
This report presents a comprehensive overview, market shares, and growth opportunities of Killer-cell immunoglobulin-like receptors (KIRs) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Killer-cell immunoglobulin-like receptors (KIRs) are a family of transmembrane glycoprotein receptors mainly expressed on natural killer cells and subsets of T cells, and the term also refers to the related commercial products and services built around KIR proteins, KIR genes, ligand recognition, and functional immune analysis. They are not visible stand-alone devices, but molecular receptors located on the cell membrane, typically composed of extracellular immunoglobulin-like domains, a transmembrane region, and a cytoplasmic tail. Structurally, KIRs can contain two or three extracellular immunoglobulin-like domains, while functionally they include inhibitory and activating receptor types. Commercial products include genotyping kits, sequencing and testing services, flow cytometry antibodies, conjugated antibodies, recombinant proteins, plasmids, cell models, and reference antibodies for drug discovery. Their mechanism is based on recognizing human leukocyte antigen-related ligands and regulating natural killer cell cytotoxicity, immune tolerance, and immune surveillance. Major use scenarios include transplant immunogenetics, natural killer cell research, oncology immunology, immune phenotyping, therapeutic antibody discovery, cell therapy development, and reproductive immunology research.
Market growth opportunities are mainly supported by three demand streams. First, transplant immunogenetics and cell therapy are increasing the need to understand donor-recipient immune background, which supports demand for genotyping, receptor-ligand analysis, and immune risk assessment. Second, the rising importance of natural killer cells in oncology, infectious disease, and autoimmune research is expanding demand for flow cytometry antibodies, recombinant proteins, and functional validation materials. Third, more specific receptor targets are moving part of the market closer to translational development, especially in therapeutic antibody programs, immune monitoring, and potential companion testing workflows.
The main market challenges are clinical evidence, standardization, and commercial scale. These products are used mostly by specialized laboratories, transplant centers, academic institutes, and drug developers, so the customer base is much narrower than that of routine clinical diagnostics. Complex polymorphism, haplotype variation, gene copy number differences, and platform-specific interpretation create technical barriers in quality control and reporting. The value of routine KIR-based decision-making still requires stronger prospective evidence, so near-term market development should be assessed as steady professional adoption rather than mass-market expansion.
Downstream demand is expected to shift from single-product purchasing toward integrated solutions. Transplant-related users will increasingly combine genotyping, ligand matching, and long-term outcome data. Oncology immunology users will focus more on receptor expression, immune-cell functional status, and treatment response monitoring. Drug developers will require higher target specificity, antibody affinity validation, cytotoxicity mechanism studies, and clinical sample-based evidence. Faster-growing product categories are likely to include high-throughput typing, conjugated antibody panels, recombinant proteins, reference antibodies, and testing services designed for clinical research.
LPI (LP Information)' newest research report, the ?Killer-cell immunoglobulin-like receptors (KIRs) Industry Forecast? looks at past sales and reviews total world Killer-cell immunoglobulin-like receptors (KIRs) sales in 2025, providing a comprehensive analysis by region and market sector of projected Killer-cell immunoglobulin-like receptors (KIRs) sales for 2026 through 2032. With Killer-cell immunoglobulin-like receptors (KIRs) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Killer-cell immunoglobulin-like receptors (KIRs) industry.
This Insight Report provides a comprehensive analysis of the global Killer-cell immunoglobulin-like receptors (KIRs) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Killer-cell immunoglobulin-like receptors (KIRs) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Killer-cell immunoglobulin-like receptors (KIRs) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Killer-cell immunoglobulin-like receptors (KIRs) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Killer-cell immunoglobulin-like receptors (KIRs).
This report presents a comprehensive overview, market shares, and growth opportunities of Killer-cell immunoglobulin-like receptors (KIRs) market by product type, application, key players and key regions and countries.
Segmentation by Type:
- KIR Genotyping Products and Services
- KIR/CD158 Antibodies and Flow Cytometry Reagents
- Recombinant KIR Proteins and Related Research Reagents
- 2D KIR Products
- 3D KIR Products
- Pan-KIR or Mixed KIR Panel Products
- Inhibitory KIR-related Products
- Activating KIR-related Products
- Mixed KIR Panel Products
- Medical Science
- Experiment
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher Scientific
- Becton Dickinson
- Beckman Coulter Life Sciences
- Bio-Rad
- Revvity
- Bio-Techne
- Miltenyi Biotec
- Merck
- Abcam
- Werfen
- CareDx
- GenDx
- HistoGenetics
- DKMS Life Science Lab
- Scisco Genetics
- Labcorp
- GeneTex
- Proteintech
- Cell Signaling Technology
- OriGene
- MyBioSource
- Aviva Systems Biology
- NSJ Bioreagents
- Boster Bio
- KACTUS
- ProteoGenix
- Biorbyt
- Abbexa
- St John?s Laboratory
- Innate Pharma
- ACROBiosystems
- Sino Biological
- GenScript
- CUSABIO
- Solarbio
- WeHelp
- CapitalBio
- Genomeditech
- Abnova
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size (2021-2032)
2.1.2 Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Killer-cell immunoglobulin-like receptors (KIRs) by Country/Region (2021, 2025 & 2032)
2.2 Killer-cell immunoglobulin-like receptors (KIRs) Segment by Type
2.2.1 KIR Genotyping Products and Services
2.2.2 KIR/CD158 Antibodies and Flow Cytometry Reagents
2.2.3 Recombinant KIR Proteins and Related Research Reagents
2.2.4 Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type
2.2.4.1 Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type (2021-2026)
2.3 Killer-cell immunoglobulin-like receptors (KIRs) Segment by Target Structure
2.3.1 2D KIR Products
2.3.2 3D KIR Products
2.3.3 Pan-KIR or Mixed KIR Panel Products
2.3.4 Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Target Structure
2.3.4.1 Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Target Structure (2021 VS 2025 VS 2032)
2.3.4.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Target Structure (2021-2026)
2.4 Killer-cell immunoglobulin-like receptors (KIRs) Segment by Function
2.4.1 Inhibitory KIR-related Products
2.4.2 Activating KIR-related Products
2.4.3 Mixed KIR Panel Products
2.4.4 Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Function
2.4.4.1 Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Function (2021 VS 2025 VS 2032)
2.4.4.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Function (2021-2026)
2.5 Killer-cell immunoglobulin-like receptors (KIRs) Segment by Application
2.5.1 Medical Science
2.5.2 Experiment
2.5.3 Other
2.5.4 Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application
2.5.4.1 Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application (2021-2026)
3 KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTORS (KIRS) MARKET SIZE BY PLAYER
3.1 Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Player
3.1.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Player (2021-2026)
3.1.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share by Player (2021-2026)
3.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTORS (KIRS) BY REGION
4.1 Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region (2021-2026)
4.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth (2021-2026)
4.4 APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth (2021-2026)
4.5 Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth (2021-2026)
4.6 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country (2021-2026)
5.2 Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026)
5.3 Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region (2021-2026)
6.2 APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026)
6.3 APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country (2021-2026)
7.2 Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026)
7.3 Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) by Region (2021-2026)
8.2 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026)
8.3 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTORS (KIRS) MARKET FORECAST
10.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Forecast by Region (2027-2032)
10.1.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Forecast by Region (2027-2032)
10.1.2 Americas Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.1.3 APAC Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.1.4 Europe Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.1.5 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.2 Americas Killer-cell immunoglobulin-like receptors (KIRs) Forecast by Country (2027-2032)
10.2.1 United States Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.2.2 Canada Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.2.3 Mexico Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.2.4 Brazil Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.3 APAC Killer-cell immunoglobulin-like receptors (KIRs) Forecast by Region (2027-2032)
10.3.1 China Killer-cell immunoglobulin-like receptors (KIRs) Market Forecast
10.3.2 Japan Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.3.3 Korea Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.3.4 Southeast Asia Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.3.5 India Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.3.6 Australia Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.4 Europe Killer-cell immunoglobulin-like receptors (KIRs) Forecast by Country (2027-2032)
10.4.1 Germany Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.4.2 France Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.4.3 UK Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.4.4 Italy Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.4.5 Russia Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.5 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Forecast by Region (2027-2032)
10.5.1 Egypt Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.5.2 South Africa Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.5.3 Israel Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.5.4 Turkey Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.6 Global Killer-cell immunoglobulin-like receptors (KIRs) Forecast by Type (2027-2032)
10.7 Global Killer-cell immunoglobulin-like receptors (KIRs) Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.1.3 Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Becton Dickinson
11.2.1 Becton Dickinson Company Information
11.2.2 Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.2.3 Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Becton Dickinson Main Business Overview
11.2.5 Becton Dickinson Latest Developments
11.3 Beckman Coulter Life Sciences
11.3.1 Beckman Coulter Life Sciences Company Information
11.3.2 Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.3.3 Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Beckman Coulter Life Sciences Main Business Overview
11.3.5 Beckman Coulter Life Sciences Latest Developments
11.4 Bio-Rad
11.4.1 Bio-Rad Company Information
11.4.2 Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.4.3 Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Bio-Rad Main Business Overview
11.4.5 Bio-Rad Latest Developments
11.5 Revvity
11.5.1 Revvity Company Information
11.5.2 Revvity Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.5.3 Revvity Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Revvity Main Business Overview
11.5.5 Revvity Latest Developments
11.6 Bio-Techne
11.6.1 Bio-Techne Company Information
11.6.2 Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.6.3 Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Bio-Techne Main Business Overview
11.6.5 Bio-Techne Latest Developments
11.7 Miltenyi Biotec
11.7.1 Miltenyi Biotec Company Information
11.7.2 Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.7.3 Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Miltenyi Biotec Main Business Overview
11.7.5 Miltenyi Biotec Latest Developments
11.8 Merck
11.8.1 Merck Company Information
11.8.2 Merck Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.8.3 Merck Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Merck Main Business Overview
11.8.5 Merck Latest Developments
11.9 Abcam
11.9.1 Abcam Company Information
11.9.2 Abcam Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.9.3 Abcam Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Abcam Main Business Overview
11.9.5 Abcam Latest Developments
11.10 Werfen
11.10.1 Werfen Company Information
11.10.2 Werfen Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.10.3 Werfen Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Werfen Main Business Overview
11.10.5 Werfen Latest Developments
11.11 CareDx
11.11.1 CareDx Company Information
11.11.2 CareDx Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.11.3 CareDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 CareDx Main Business Overview
11.11.5 CareDx Latest Developments
11.12 GenDx
11.12.1 GenDx Company Information
11.12.2 GenDx Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.12.3 GenDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 GenDx Main Business Overview
11.12.5 GenDx Latest Developments
11.13 HistoGenetics
11.13.1 HistoGenetics Company Information
11.13.2 HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.13.3 HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 HistoGenetics Main Business Overview
11.13.5 HistoGenetics Latest Developments
11.14 DKMS Life Science Lab
11.14.1 DKMS Life Science Lab Company Information
11.14.2 DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.14.3 DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 DKMS Life Science Lab Main Business Overview
11.14.5 DKMS Life Science Lab Latest Developments
11.15 Scisco Genetics
11.15.1 Scisco Genetics Company Information
11.15.2 Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.15.3 Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Scisco Genetics Main Business Overview
11.15.5 Scisco Genetics Latest Developments
11.16 Labcorp
11.16.1 Labcorp Company Information
11.16.2 Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.16.3 Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Labcorp Main Business Overview
11.16.5 Labcorp Latest Developments
11.17 GeneTex
11.17.1 GeneTex Company Information
11.17.2 GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.17.3 GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 GeneTex Main Business Overview
11.17.5 GeneTex Latest Developments
11.18 Proteintech
11.18.1 Proteintech Company Information
11.18.2 Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.18.3 Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Proteintech Main Business Overview
11.18.5 Proteintech Latest Developments
11.19 Cell Signaling Technology
11.19.1 Cell Signaling Technology Company Information
11.19.2 Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.19.3 Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Cell Signaling Technology Main Business Overview
11.19.5 Cell Signaling Technology Latest Developments
11.20 OriGene
11.20.1 OriGene Company Information
11.20.2 OriGene Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.20.3 OriGene Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 OriGene Main Business Overview
11.20.5 OriGene Latest Developments
11.21 MyBioSource
11.21.1 MyBioSource Company Information
11.21.2 MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.21.3 MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 MyBioSource Main Business Overview
11.21.5 MyBioSource Latest Developments
11.22 Aviva Systems Biology
11.22.1 Aviva Systems Biology Company Information
11.22.2 Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.22.3 Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Aviva Systems Biology Main Business Overview
11.22.5 Aviva Systems Biology Latest Developments
11.23 NSJ Bioreagents
11.23.1 NSJ Bioreagents Company Information
11.23.2 NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.23.3 NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 NSJ Bioreagents Main Business Overview
11.23.5 NSJ Bioreagents Latest Developments
11.24 Boster Bio
11.24.1 Boster Bio Company Information
11.24.2 Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.24.3 Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Boster Bio Main Business Overview
11.24.5 Boster Bio Latest Developments
11.25 KACTUS
11.25.1 KACTUS Company Information
11.25.2 KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.25.3 KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 KACTUS Main Business Overview
11.25.5 KACTUS Latest Developments
11.26 ProteoGenix
11.26.1 ProteoGenix Company Information
11.26.2 ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.26.3 ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 ProteoGenix Main Business Overview
11.26.5 ProteoGenix Latest Developments
11.27 Biorbyt
11.27.1 Biorbyt Company Information
11.27.2 Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.27.3 Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 Biorbyt Main Business Overview
11.27.5 Biorbyt Latest Developments
11.28 Abbexa
11.28.1 Abbexa Company Information
11.28.2 Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.28.3 Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 Abbexa Main Business Overview
11.28.5 Abbexa Latest Developments
11.29 St John?s Laboratory
11.29.1 St John?s Laboratory Company Information
11.29.2 St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.29.3 St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 St John?s Laboratory Main Business Overview
11.29.5 St John?s Laboratory Latest Developments
11.30 Innate Pharma
11.30.1 Innate Pharma Company Information
11.30.2 Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.30.3 Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.30.4 Innate Pharma Main Business Overview
11.30.5 Innate Pharma Latest Developments
11.31 ACROBiosystems
11.31.1 ACROBiosystems Company Information
11.31.2 ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.31.3 ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.31.4 ACROBiosystems Main Business Overview
11.31.5 ACROBiosystems Latest Developments
11.32 Sino Biological
11.32.1 Sino Biological Company Information
11.32.2 Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.32.3 Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.32.4 Sino Biological Main Business Overview
11.32.5 Sino Biological Latest Developments
11.33 GenScript
11.33.1 GenScript Company Information
11.33.2 GenScript Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.33.3 GenScript Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.33.4 GenScript Main Business Overview
11.33.5 GenScript Latest Developments
11.34 CUSABIO
11.34.1 CUSABIO Company Information
11.34.2 CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.34.3 CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.34.4 CUSABIO Main Business Overview
11.34.5 CUSABIO Latest Developments
11.35 Solarbio
11.35.1 Solarbio Company Information
11.35.2 Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.35.3 Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.35.4 Solarbio Main Business Overview
11.35.5 Solarbio Latest Developments
11.36 WeHelp
11.36.1 WeHelp Company Information
11.36.2 WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.36.3 WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.36.4 WeHelp Main Business Overview
11.36.5 WeHelp Latest Developments
11.37 CapitalBio
11.37.1 CapitalBio Company Information
11.37.2 CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.37.3 CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.37.4 CapitalBio Main Business Overview
11.37.5 CapitalBio Latest Developments
11.38 Genomeditech
11.38.1 Genomeditech Company Information
11.38.2 Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.38.3 Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.38.4 Genomeditech Main Business Overview
11.38.5 Genomeditech Latest Developments
11.39 Abnova
11.39.1 Abnova Company Information
11.39.2 Abnova Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.39.3 Abnova Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.39.4 Abnova Main Business Overview
11.39.5 Abnova Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size (2021-2032)
2.1.2 Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Killer-cell immunoglobulin-like receptors (KIRs) by Country/Region (2021, 2025 & 2032)
2.2 Killer-cell immunoglobulin-like receptors (KIRs) Segment by Type
2.2.1 KIR Genotyping Products and Services
2.2.2 KIR/CD158 Antibodies and Flow Cytometry Reagents
2.2.3 Recombinant KIR Proteins and Related Research Reagents
2.2.4 Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type
2.2.4.1 Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type (2021-2026)
2.3 Killer-cell immunoglobulin-like receptors (KIRs) Segment by Target Structure
2.3.1 2D KIR Products
2.3.2 3D KIR Products
2.3.3 Pan-KIR or Mixed KIR Panel Products
2.3.4 Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Target Structure
2.3.4.1 Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Target Structure (2021 VS 2025 VS 2032)
2.3.4.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Target Structure (2021-2026)
2.4 Killer-cell immunoglobulin-like receptors (KIRs) Segment by Function
2.4.1 Inhibitory KIR-related Products
2.4.2 Activating KIR-related Products
2.4.3 Mixed KIR Panel Products
2.4.4 Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Function
2.4.4.1 Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Function (2021 VS 2025 VS 2032)
2.4.4.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Function (2021-2026)
2.5 Killer-cell immunoglobulin-like receptors (KIRs) Segment by Application
2.5.1 Medical Science
2.5.2 Experiment
2.5.3 Other
2.5.4 Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application
2.5.4.1 Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application (2021-2026)
3 KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTORS (KIRS) MARKET SIZE BY PLAYER
3.1 Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Player
3.1.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Player (2021-2026)
3.1.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share by Player (2021-2026)
3.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTORS (KIRS) BY REGION
4.1 Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region (2021-2026)
4.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth (2021-2026)
4.4 APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth (2021-2026)
4.5 Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth (2021-2026)
4.6 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country (2021-2026)
5.2 Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026)
5.3 Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region (2021-2026)
6.2 APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026)
6.3 APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country (2021-2026)
7.2 Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026)
7.3 Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) by Region (2021-2026)
8.2 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026)
8.3 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTORS (KIRS) MARKET FORECAST
10.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Forecast by Region (2027-2032)
10.1.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Forecast by Region (2027-2032)
10.1.2 Americas Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.1.3 APAC Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.1.4 Europe Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.1.5 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.2 Americas Killer-cell immunoglobulin-like receptors (KIRs) Forecast by Country (2027-2032)
10.2.1 United States Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.2.2 Canada Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.2.3 Mexico Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.2.4 Brazil Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.3 APAC Killer-cell immunoglobulin-like receptors (KIRs) Forecast by Region (2027-2032)
10.3.1 China Killer-cell immunoglobulin-like receptors (KIRs) Market Forecast
10.3.2 Japan Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.3.3 Korea Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.3.4 Southeast Asia Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.3.5 India Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.3.6 Australia Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.4 Europe Killer-cell immunoglobulin-like receptors (KIRs) Forecast by Country (2027-2032)
10.4.1 Germany Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.4.2 France Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.4.3 UK Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.4.4 Italy Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.4.5 Russia Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.5 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Forecast by Region (2027-2032)
10.5.1 Egypt Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.5.2 South Africa Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.5.3 Israel Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.5.4 Turkey Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
10.6 Global Killer-cell immunoglobulin-like receptors (KIRs) Forecast by Type (2027-2032)
10.7 Global Killer-cell immunoglobulin-like receptors (KIRs) Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Killer-cell immunoglobulin-like receptors (KIRs) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.1.3 Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Becton Dickinson
11.2.1 Becton Dickinson Company Information
11.2.2 Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.2.3 Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Becton Dickinson Main Business Overview
11.2.5 Becton Dickinson Latest Developments
11.3 Beckman Coulter Life Sciences
11.3.1 Beckman Coulter Life Sciences Company Information
11.3.2 Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.3.3 Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Beckman Coulter Life Sciences Main Business Overview
11.3.5 Beckman Coulter Life Sciences Latest Developments
11.4 Bio-Rad
11.4.1 Bio-Rad Company Information
11.4.2 Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.4.3 Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Bio-Rad Main Business Overview
11.4.5 Bio-Rad Latest Developments
11.5 Revvity
11.5.1 Revvity Company Information
11.5.2 Revvity Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.5.3 Revvity Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Revvity Main Business Overview
11.5.5 Revvity Latest Developments
11.6 Bio-Techne
11.6.1 Bio-Techne Company Information
11.6.2 Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.6.3 Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Bio-Techne Main Business Overview
11.6.5 Bio-Techne Latest Developments
11.7 Miltenyi Biotec
11.7.1 Miltenyi Biotec Company Information
11.7.2 Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.7.3 Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Miltenyi Biotec Main Business Overview
11.7.5 Miltenyi Biotec Latest Developments
11.8 Merck
11.8.1 Merck Company Information
11.8.2 Merck Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.8.3 Merck Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Merck Main Business Overview
11.8.5 Merck Latest Developments
11.9 Abcam
11.9.1 Abcam Company Information
11.9.2 Abcam Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.9.3 Abcam Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Abcam Main Business Overview
11.9.5 Abcam Latest Developments
11.10 Werfen
11.10.1 Werfen Company Information
11.10.2 Werfen Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.10.3 Werfen Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Werfen Main Business Overview
11.10.5 Werfen Latest Developments
11.11 CareDx
11.11.1 CareDx Company Information
11.11.2 CareDx Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.11.3 CareDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 CareDx Main Business Overview
11.11.5 CareDx Latest Developments
11.12 GenDx
11.12.1 GenDx Company Information
11.12.2 GenDx Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.12.3 GenDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 GenDx Main Business Overview
11.12.5 GenDx Latest Developments
11.13 HistoGenetics
11.13.1 HistoGenetics Company Information
11.13.2 HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.13.3 HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 HistoGenetics Main Business Overview
11.13.5 HistoGenetics Latest Developments
11.14 DKMS Life Science Lab
11.14.1 DKMS Life Science Lab Company Information
11.14.2 DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.14.3 DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 DKMS Life Science Lab Main Business Overview
11.14.5 DKMS Life Science Lab Latest Developments
11.15 Scisco Genetics
11.15.1 Scisco Genetics Company Information
11.15.2 Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.15.3 Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Scisco Genetics Main Business Overview
11.15.5 Scisco Genetics Latest Developments
11.16 Labcorp
11.16.1 Labcorp Company Information
11.16.2 Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.16.3 Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Labcorp Main Business Overview
11.16.5 Labcorp Latest Developments
11.17 GeneTex
11.17.1 GeneTex Company Information
11.17.2 GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.17.3 GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 GeneTex Main Business Overview
11.17.5 GeneTex Latest Developments
11.18 Proteintech
11.18.1 Proteintech Company Information
11.18.2 Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.18.3 Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Proteintech Main Business Overview
11.18.5 Proteintech Latest Developments
11.19 Cell Signaling Technology
11.19.1 Cell Signaling Technology Company Information
11.19.2 Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.19.3 Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Cell Signaling Technology Main Business Overview
11.19.5 Cell Signaling Technology Latest Developments
11.20 OriGene
11.20.1 OriGene Company Information
11.20.2 OriGene Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.20.3 OriGene Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 OriGene Main Business Overview
11.20.5 OriGene Latest Developments
11.21 MyBioSource
11.21.1 MyBioSource Company Information
11.21.2 MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.21.3 MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 MyBioSource Main Business Overview
11.21.5 MyBioSource Latest Developments
11.22 Aviva Systems Biology
11.22.1 Aviva Systems Biology Company Information
11.22.2 Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.22.3 Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Aviva Systems Biology Main Business Overview
11.22.5 Aviva Systems Biology Latest Developments
11.23 NSJ Bioreagents
11.23.1 NSJ Bioreagents Company Information
11.23.2 NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.23.3 NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 NSJ Bioreagents Main Business Overview
11.23.5 NSJ Bioreagents Latest Developments
11.24 Boster Bio
11.24.1 Boster Bio Company Information
11.24.2 Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.24.3 Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Boster Bio Main Business Overview
11.24.5 Boster Bio Latest Developments
11.25 KACTUS
11.25.1 KACTUS Company Information
11.25.2 KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.25.3 KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 KACTUS Main Business Overview
11.25.5 KACTUS Latest Developments
11.26 ProteoGenix
11.26.1 ProteoGenix Company Information
11.26.2 ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.26.3 ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 ProteoGenix Main Business Overview
11.26.5 ProteoGenix Latest Developments
11.27 Biorbyt
11.27.1 Biorbyt Company Information
11.27.2 Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.27.3 Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 Biorbyt Main Business Overview
11.27.5 Biorbyt Latest Developments
11.28 Abbexa
11.28.1 Abbexa Company Information
11.28.2 Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.28.3 Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 Abbexa Main Business Overview
11.28.5 Abbexa Latest Developments
11.29 St John?s Laboratory
11.29.1 St John?s Laboratory Company Information
11.29.2 St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.29.3 St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 St John?s Laboratory Main Business Overview
11.29.5 St John?s Laboratory Latest Developments
11.30 Innate Pharma
11.30.1 Innate Pharma Company Information
11.30.2 Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.30.3 Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.30.4 Innate Pharma Main Business Overview
11.30.5 Innate Pharma Latest Developments
11.31 ACROBiosystems
11.31.1 ACROBiosystems Company Information
11.31.2 ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.31.3 ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.31.4 ACROBiosystems Main Business Overview
11.31.5 ACROBiosystems Latest Developments
11.32 Sino Biological
11.32.1 Sino Biological Company Information
11.32.2 Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.32.3 Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.32.4 Sino Biological Main Business Overview
11.32.5 Sino Biological Latest Developments
11.33 GenScript
11.33.1 GenScript Company Information
11.33.2 GenScript Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.33.3 GenScript Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.33.4 GenScript Main Business Overview
11.33.5 GenScript Latest Developments
11.34 CUSABIO
11.34.1 CUSABIO Company Information
11.34.2 CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.34.3 CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.34.4 CUSABIO Main Business Overview
11.34.5 CUSABIO Latest Developments
11.35 Solarbio
11.35.1 Solarbio Company Information
11.35.2 Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.35.3 Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.35.4 Solarbio Main Business Overview
11.35.5 Solarbio Latest Developments
11.36 WeHelp
11.36.1 WeHelp Company Information
11.36.2 WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.36.3 WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.36.4 WeHelp Main Business Overview
11.36.5 WeHelp Latest Developments
11.37 CapitalBio
11.37.1 CapitalBio Company Information
11.37.2 CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.37.3 CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.37.4 CapitalBio Main Business Overview
11.37.5 CapitalBio Latest Developments
11.38 Genomeditech
11.38.1 Genomeditech Company Information
11.38.2 Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.38.3 Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.38.4 Genomeditech Main Business Overview
11.38.5 Genomeditech Latest Developments
11.39 Abnova
11.39.1 Abnova Company Information
11.39.2 Abnova Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
11.39.3 Abnova Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
11.39.4 Abnova Main Business Overview
11.39.5 Abnova Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Killer-cell immunoglobulin-like receptors (KIRs) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of KIR Genotyping Products and Services
Table 4. Major Players of KIR/CD158 Antibodies and Flow Cytometry Reagents
Table 5. Major Players of Recombinant KIR Proteins and Related Research Reagents
Table 6. Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type (2021-2026)
Table 9. Major Players of 2D KIR Products
Table 10. Major Players of 3D KIR Products
Table 11. Major Players of Pan-KIR or Mixed KIR Panel Products
Table 12. Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Target Structure (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Target Structure (2021-2026) & ($ millions)
Table 14. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Target Structure (2021-2026)
Table 15. Major Players of Inhibitory KIR-related Products
Table 16. Major Players of Activating KIR-related Products
Table 17. Major Players of Mixed KIR Panel Products
Table 18. Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Function (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Function (2021-2026) & ($ millions)
Table 20. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Function (2021-2026)
Table 21. Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application (2021-2026)
Table 24. Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share by Player (2021-2026)
Table 26. Killer-cell immunoglobulin-like receptors (KIRs) Key Players Head office and Products Offered
Table 27. Killer-cell immunoglobulin-like receptors (KIRs) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Region (2021-2026)
Table 32. Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Country (2021-2026)
Table 36. Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type (2021-2026)
Table 38. Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application (2021-2026)
Table 40. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Region (2021-2026)
Table 42. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Country (2021-2026)
Table 46. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Killer-cell immunoglobulin-like receptors (KIRs)
Table 52. Key Market Challenges & Risks of Killer-cell immunoglobulin-like receptors (KIRs)
Table 53. Key Industry Trends of Killer-cell immunoglobulin-like receptors (KIRs)
Table 54. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Thermo Fisher Scientific Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 59. Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 60. Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Thermo Fisher Scientific Main Business
Table 62. Thermo Fisher Scientific Latest Developments
Table 63. Becton Dickinson Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 64. Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 65. Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Becton Dickinson Main Business
Table 67. Becton Dickinson Latest Developments
Table 68. Beckman Coulter Life Sciences Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 69. Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 70. Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Beckman Coulter Life Sciences Main Business
Table 72. Beckman Coulter Life Sciences Latest Developments
Table 73. Bio-Rad Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 74. Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 75. Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Bio-Rad Main Business
Table 77. Bio-Rad Latest Developments
Table 78. Revvity Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 79. Revvity Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 80. Revvity Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Revvity Main Business
Table 82. Revvity Latest Developments
Table 83. Bio-Techne Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 84. Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 85. Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Bio-Techne Main Business
Table 87. Bio-Techne Latest Developments
Table 88. Miltenyi Biotec Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 89. Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 90. Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Miltenyi Biotec Main Business
Table 92. Miltenyi Biotec Latest Developments
Table 93. Merck Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 94. Merck Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 95. Merck Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Merck Main Business
Table 97. Merck Latest Developments
Table 98. Abcam Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 99. Abcam Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 100. Abcam Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Abcam Main Business
Table 102. Abcam Latest Developments
Table 103. Werfen Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 104. Werfen Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 105. Werfen Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Werfen Main Business
Table 107. Werfen Latest Developments
Table 108. CareDx Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 109. CareDx Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 110. CareDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. CareDx Main Business
Table 112. CareDx Latest Developments
Table 113. GenDx Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 114. GenDx Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 115. GenDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. GenDx Main Business
Table 117. GenDx Latest Developments
Table 118. HistoGenetics Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 119. HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 120. HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. HistoGenetics Main Business
Table 122. HistoGenetics Latest Developments
Table 123. DKMS Life Science Lab Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 124. DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 125. DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. DKMS Life Science Lab Main Business
Table 127. DKMS Life Science Lab Latest Developments
Table 128. Scisco Genetics Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 129. Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 130. Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Scisco Genetics Main Business
Table 132. Scisco Genetics Latest Developments
Table 133. Labcorp Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 134. Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 135. Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Labcorp Main Business
Table 137. Labcorp Latest Developments
Table 138. GeneTex Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 139. GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 140. GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. GeneTex Main Business
Table 142. GeneTex Latest Developments
Table 143. Proteintech Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 144. Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 145. Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. Proteintech Main Business
Table 147. Proteintech Latest Developments
Table 148. Cell Signaling Technology Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 149. Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 150. Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. Cell Signaling Technology Main Business
Table 152. Cell Signaling Technology Latest Developments
Table 153. OriGene Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 154. OriGene Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 155. OriGene Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 156. OriGene Main Business
Table 157. OriGene Latest Developments
Table 158. MyBioSource Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 159. MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 160. MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 161. MyBioSource Main Business
Table 162. MyBioSource Latest Developments
Table 163. Aviva Systems Biology Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 164. Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 165. Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 166. Aviva Systems Biology Main Business
Table 167. Aviva Systems Biology Latest Developments
Table 168. NSJ Bioreagents Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 169. NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 170. NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 171. NSJ Bioreagents Main Business
Table 172. NSJ Bioreagents Latest Developments
Table 173. Boster Bio Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 174. Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 175. Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 176. Boster Bio Main Business
Table 177. Boster Bio Latest Developments
Table 178. KACTUS Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 179. KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 180. KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 181. KACTUS Main Business
Table 182. KACTUS Latest Developments
Table 183. ProteoGenix Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 184. ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 185. ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 186. ProteoGenix Main Business
Table 187. ProteoGenix Latest Developments
Table 188. Biorbyt Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 189. Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 190. Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 191. Biorbyt Main Business
Table 192. Biorbyt Latest Developments
Table 193. Abbexa Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 194. Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 195. Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 196. Abbexa Main Business
Table 197. Abbexa Latest Developments
Table 198. St John?s Laboratory Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 199. St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 200. St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 201. St John?s Laboratory Main Business
Table 202. St John?s Laboratory Latest Developments
Table 203. Innate Pharma Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 204. Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 205. Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 206. Innate Pharma Main Business
Table 207. Innate Pharma Latest Developments
Table 208. ACROBiosystems Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 209. ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 210. ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 211. ACROBiosystems Main Business
Table 212. ACROBiosystems Latest Developments
Table 213. Sino Biological Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 214. Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 215. Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 216. Sino Biological Main Business
Table 217. Sino Biological Latest Developments
Table 218. GenScript Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 219. GenScript Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 220. GenScript Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 221. GenScript Main Business
Table 222. GenScript Latest Developments
Table 223. CUSABIO Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 224. CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 225. CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 226. CUSABIO Main Business
Table 227. CUSABIO Latest Developments
Table 228. Solarbio Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 229. Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 230. Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 231. Solarbio Main Business
Table 232. Solarbio Latest Developments
Table 233. WeHelp Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 234. WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 235. WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 236. WeHelp Main Business
Table 237. WeHelp Latest Developments
Table 238. CapitalBio Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 239. CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 240. CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 241. CapitalBio Main Business
Table 242. CapitalBio Latest Developments
Table 243. Genomeditech Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 244. Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 245. Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 246. Genomeditech Main Business
Table 247. Genomeditech Latest Developments
Table 248. Abnova Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 249. Abnova Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 250. Abnova Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 251. Abnova Main Business
Table 252. Abnova Latest Developments
Table 1. Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Killer-cell immunoglobulin-like receptors (KIRs) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of KIR Genotyping Products and Services
Table 4. Major Players of KIR/CD158 Antibodies and Flow Cytometry Reagents
Table 5. Major Players of Recombinant KIR Proteins and Related Research Reagents
Table 6. Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type (2021-2026)
Table 9. Major Players of 2D KIR Products
Table 10. Major Players of 3D KIR Products
Table 11. Major Players of Pan-KIR or Mixed KIR Panel Products
Table 12. Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Target Structure (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Target Structure (2021-2026) & ($ millions)
Table 14. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Target Structure (2021-2026)
Table 15. Major Players of Inhibitory KIR-related Products
Table 16. Major Players of Activating KIR-related Products
Table 17. Major Players of Mixed KIR Panel Products
Table 18. Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Function (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Function (2021-2026) & ($ millions)
Table 20. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Function (2021-2026)
Table 21. Killer-cell immunoglobulin-like receptors (KIRs) Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application (2021-2026)
Table 24. Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share by Player (2021-2026)
Table 26. Killer-cell immunoglobulin-like receptors (KIRs) Key Players Head office and Products Offered
Table 27. Killer-cell immunoglobulin-like receptors (KIRs) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Region (2021-2026)
Table 32. Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Country (2021-2026)
Table 36. Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type (2021-2026)
Table 38. Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application (2021-2026)
Table 40. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Region (2021-2026)
Table 42. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Country (2021-2026)
Table 46. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Killer-cell immunoglobulin-like receptors (KIRs)
Table 52. Key Market Challenges & Risks of Killer-cell immunoglobulin-like receptors (KIRs)
Table 53. Key Industry Trends of Killer-cell immunoglobulin-like receptors (KIRs)
Table 54. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Thermo Fisher Scientific Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 59. Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 60. Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Thermo Fisher Scientific Main Business
Table 62. Thermo Fisher Scientific Latest Developments
Table 63. Becton Dickinson Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 64. Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 65. Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Becton Dickinson Main Business
Table 67. Becton Dickinson Latest Developments
Table 68. Beckman Coulter Life Sciences Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 69. Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 70. Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Beckman Coulter Life Sciences Main Business
Table 72. Beckman Coulter Life Sciences Latest Developments
Table 73. Bio-Rad Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 74. Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 75. Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Bio-Rad Main Business
Table 77. Bio-Rad Latest Developments
Table 78. Revvity Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 79. Revvity Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 80. Revvity Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Revvity Main Business
Table 82. Revvity Latest Developments
Table 83. Bio-Techne Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 84. Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 85. Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Bio-Techne Main Business
Table 87. Bio-Techne Latest Developments
Table 88. Miltenyi Biotec Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 89. Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 90. Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Miltenyi Biotec Main Business
Table 92. Miltenyi Biotec Latest Developments
Table 93. Merck Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 94. Merck Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 95. Merck Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Merck Main Business
Table 97. Merck Latest Developments
Table 98. Abcam Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 99. Abcam Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 100. Abcam Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Abcam Main Business
Table 102. Abcam Latest Developments
Table 103. Werfen Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 104. Werfen Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 105. Werfen Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Werfen Main Business
Table 107. Werfen Latest Developments
Table 108. CareDx Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 109. CareDx Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 110. CareDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. CareDx Main Business
Table 112. CareDx Latest Developments
Table 113. GenDx Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 114. GenDx Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 115. GenDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. GenDx Main Business
Table 117. GenDx Latest Developments
Table 118. HistoGenetics Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 119. HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 120. HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. HistoGenetics Main Business
Table 122. HistoGenetics Latest Developments
Table 123. DKMS Life Science Lab Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 124. DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 125. DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. DKMS Life Science Lab Main Business
Table 127. DKMS Life Science Lab Latest Developments
Table 128. Scisco Genetics Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 129. Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 130. Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Scisco Genetics Main Business
Table 132. Scisco Genetics Latest Developments
Table 133. Labcorp Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 134. Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 135. Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Labcorp Main Business
Table 137. Labcorp Latest Developments
Table 138. GeneTex Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 139. GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 140. GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. GeneTex Main Business
Table 142. GeneTex Latest Developments
Table 143. Proteintech Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 144. Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 145. Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. Proteintech Main Business
Table 147. Proteintech Latest Developments
Table 148. Cell Signaling Technology Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 149. Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 150. Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. Cell Signaling Technology Main Business
Table 152. Cell Signaling Technology Latest Developments
Table 153. OriGene Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 154. OriGene Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 155. OriGene Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 156. OriGene Main Business
Table 157. OriGene Latest Developments
Table 158. MyBioSource Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 159. MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 160. MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 161. MyBioSource Main Business
Table 162. MyBioSource Latest Developments
Table 163. Aviva Systems Biology Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 164. Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 165. Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 166. Aviva Systems Biology Main Business
Table 167. Aviva Systems Biology Latest Developments
Table 168. NSJ Bioreagents Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 169. NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 170. NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 171. NSJ Bioreagents Main Business
Table 172. NSJ Bioreagents Latest Developments
Table 173. Boster Bio Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 174. Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 175. Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 176. Boster Bio Main Business
Table 177. Boster Bio Latest Developments
Table 178. KACTUS Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 179. KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 180. KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 181. KACTUS Main Business
Table 182. KACTUS Latest Developments
Table 183. ProteoGenix Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 184. ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 185. ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 186. ProteoGenix Main Business
Table 187. ProteoGenix Latest Developments
Table 188. Biorbyt Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 189. Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 190. Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 191. Biorbyt Main Business
Table 192. Biorbyt Latest Developments
Table 193. Abbexa Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 194. Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 195. Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 196. Abbexa Main Business
Table 197. Abbexa Latest Developments
Table 198. St John?s Laboratory Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 199. St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 200. St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 201. St John?s Laboratory Main Business
Table 202. St John?s Laboratory Latest Developments
Table 203. Innate Pharma Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 204. Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 205. Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 206. Innate Pharma Main Business
Table 207. Innate Pharma Latest Developments
Table 208. ACROBiosystems Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 209. ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 210. ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 211. ACROBiosystems Main Business
Table 212. ACROBiosystems Latest Developments
Table 213. Sino Biological Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 214. Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 215. Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 216. Sino Biological Main Business
Table 217. Sino Biological Latest Developments
Table 218. GenScript Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 219. GenScript Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 220. GenScript Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 221. GenScript Main Business
Table 222. GenScript Latest Developments
Table 223. CUSABIO Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 224. CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 225. CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 226. CUSABIO Main Business
Table 227. CUSABIO Latest Developments
Table 228. Solarbio Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 229. Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 230. Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 231. Solarbio Main Business
Table 232. Solarbio Latest Developments
Table 233. WeHelp Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 234. WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 235. WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 236. WeHelp Main Business
Table 237. WeHelp Latest Developments
Table 238. CapitalBio Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 239. CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 240. CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 241. CapitalBio Main Business
Table 242. CapitalBio Latest Developments
Table 243. Genomeditech Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 244. Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 245. Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 246. Genomeditech Main Business
Table 247. Genomeditech Latest Developments
Table 248. Abnova Details, Company Type, Killer-cell immunoglobulin-like receptors (KIRs) Area Served and Its Competitors
Table 249. Abnova Killer-cell immunoglobulin-like receptors (KIRs) Product Offered
Table 250. Abnova Killer-cell immunoglobulin-like receptors (KIRs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 251. Abnova Main Business
Table 252. Abnova Latest Developments
LIST OF FIGURES
Figure 1. Killer-cell immunoglobulin-like receptors (KIRs) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Killer-cell immunoglobulin-like receptors (KIRs) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Killer-cell immunoglobulin-like receptors (KIRs) Sales Market Share by Country/Region (2025)
Figure 8. Killer-cell immunoglobulin-like receptors (KIRs) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type in 2025
Figure 10. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Target Structure in 2025
Figure 11. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Function in 2025
Figure 12. Killer-cell immunoglobulin-like receptors (KIRs) in Medical Science
Figure 13. Global Killer-cell immunoglobulin-like receptors (KIRs) Market: Medical Science (2021-2026) & ($ millions)
Figure 14. Killer-cell immunoglobulin-like receptors (KIRs) in Experiment
Figure 15. Global Killer-cell immunoglobulin-like receptors (KIRs) Market: Experiment (2021-2026) & ($ millions)
Figure 16. Killer-cell immunoglobulin-like receptors (KIRs) in Other
Figure 17. Global Killer-cell immunoglobulin-like receptors (KIRs) Market: Other (2021-2026) & ($ millions)
Figure 18. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application in 2025
Figure 19. Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share by Player in 2025
Figure 20. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Region (2021-2026)
Figure 21. Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2021-2026 ($ millions)
Figure 22. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2021-2026 ($ millions)
Figure 23. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2021-2026 ($ millions)
Figure 25. Americas Killer-cell immunoglobulin-like receptors (KIRs) Value Market Share by Country in 2025
Figure 26. United States Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Region in 2025
Figure 31. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type (2021-2026)
Figure 32. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application (2021-2026)
Figure 33. China Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 37. India Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Country in 2025
Figure 40. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type (2021-2026)
Figure 41. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application (2021-2026)
Figure 42. Germany Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 43. France Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 56. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 57. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 59. United States Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 60. Canada Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 61. Mexico Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 62. Brazil Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 63. China Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 64. Japan Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 65. Korea Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 67. India Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 68. Australia Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 69. Germany Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 70. France Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 71. UK Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 72. Italy Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 73. Russia Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 74. Egypt Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 75. South Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 76. Israel Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 77. Turkey Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 78. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 1. Killer-cell immunoglobulin-like receptors (KIRs) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Killer-cell immunoglobulin-like receptors (KIRs) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Killer-cell immunoglobulin-like receptors (KIRs) Sales Market Share by Country/Region (2025)
Figure 8. Killer-cell immunoglobulin-like receptors (KIRs) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type in 2025
Figure 10. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Target Structure in 2025
Figure 11. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Function in 2025
Figure 12. Killer-cell immunoglobulin-like receptors (KIRs) in Medical Science
Figure 13. Global Killer-cell immunoglobulin-like receptors (KIRs) Market: Medical Science (2021-2026) & ($ millions)
Figure 14. Killer-cell immunoglobulin-like receptors (KIRs) in Experiment
Figure 15. Global Killer-cell immunoglobulin-like receptors (KIRs) Market: Experiment (2021-2026) & ($ millions)
Figure 16. Killer-cell immunoglobulin-like receptors (KIRs) in Other
Figure 17. Global Killer-cell immunoglobulin-like receptors (KIRs) Market: Other (2021-2026) & ($ millions)
Figure 18. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application in 2025
Figure 19. Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue Market Share by Player in 2025
Figure 20. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Region (2021-2026)
Figure 21. Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2021-2026 ($ millions)
Figure 22. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2021-2026 ($ millions)
Figure 23. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2021-2026 ($ millions)
Figure 25. Americas Killer-cell immunoglobulin-like receptors (KIRs) Value Market Share by Country in 2025
Figure 26. United States Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Region in 2025
Figure 31. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type (2021-2026)
Figure 32. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application (2021-2026)
Figure 33. China Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 37. India Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Country in 2025
Figure 40. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type (2021-2026)
Figure 41. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application (2021-2026)
Figure 42. Germany Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 43. France Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Killer-cell immunoglobulin-like receptors (KIRs) Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 56. APAC Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 57. Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 59. United States Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 60. Canada Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 61. Mexico Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 62. Brazil Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 63. China Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 64. Japan Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 65. Korea Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 67. India Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 68. Australia Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 69. Germany Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 70. France Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 71. UK Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 72. Italy Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 73. Russia Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 74. Egypt Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 75. South Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 76. Israel Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 77. Turkey Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
Figure 78. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Killer-cell immunoglobulin-like receptors (KIRs) Market Size 2027-2032 ($ millions)
